| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.009 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0066 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |